Skin color improving composition as well as preparation method and application thereof
Through compositions of 3-o-ethyl ascorbic acid and other components, interfere with melanin biosynthesis, improve skin microcirculation and glycosylation end product formation, solve the problem that existing whitening products are difficult to remove yellowing and even skin tone, and achieve multi-angle Improves skin tone and improves skin firmness.
Patent Information
- Application Number
- CN202411326002.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-23
- Publication Date
- 2024-11-26
AI Technical Summary
Existing whitening products are difficult to meet consumers' needs for improving skin tone such as removing yellow and evenlying skin tone. The whitening effect is insufficient, mainly focusing on the synthesis and metabolic process of melanin, and failing to improve skin tone from multiple angles.
Compositions using 3-o-ethyl ascorbic acid, carnosine, reed extract, licorice root extract, salvia miltiorrhiza root extract, angelica root extract, wolfberry root extract, and jujube extract to interfere with melanin through multiple channels Biosynthesis, inhibits tyrosinase activity, improves skin microcirculation, prevents the formation of glycosylation end products and fat oxidation end products, and promotes skin repair and firmness improvement.
Significantly improves skin tone, has significant whitening effect, can improve skin tone from multiple angles, prevent dullness and photoaging, improves skin firmness and elasticity, has high stability and high efficiency additive characteristics, suitable for the preparation of skin care products, meets the needs of Use needs of different groups of people.
Smart Images

Figure BDA0005055438650000071 
Figure BDA0005055438650000081 
Figure BDA0005055438650000091
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of A61K8 / 18, and in particular to a skin color improving composition and a preparation method and application thereof. Background Art
[0002] The 2024 Chinese Women's Skin Whitening Research Report points out that among Chinese female consumers aged between 20 and 50, more than 80% have whitening needs, and forming a healthy and fair skin tone has always been a consumer requirement for whitening products. However, there are many factors that affect skin tone. In addition to the accumulation of melanin caused by ultraviolet rays and other factors, which is the main cause of skin tone, skin redness caused by damaged skin barrier, photoaging, post-inflammatory pigmentation, accumulation of AGEs (advanced glycation end products), and retention of bilirubin in the local skin under stress conditions, which causes skin yellowing, will also affect the formation of a healthy and fair skin tone.
[0003] A Chinese patent (publication number CN 112245532 A) discloses a composition and application of traditional Chinese medicine for purifying and whitening skin. The composition uses safe traditional Chinese medicine whitening ingredients, including selenium-enriched yam powder, lotus root powder, selenium-enriched chicken egg powder, wolfberry extract, Poria extract, Polygonatum odoratum extract, Angelica dahurica extract, Astragalus extract, Ganoderma lucidum spore powder extract, Dendrobium candidum extract, Ginkgo extract, Perilla extract, Bletilla striata extract, Tribulus terrestris extract, which can achieve the effect of safe beauty freckle removal. However, the composition mainly focuses on common melanin targets, and the skin color dimension is relatively single, and the whitening effect is insufficient. A Chinese patent (publication number CN117064828A) discloses a uniform skin color whitening composition and its preparation method and application. The composition includes calla lily extract, North American pine bark extract, and sea daffodil extract. The composition is not limited to the traditional pathways of inhibiting tyrosinase activity, inhibiting the transfer of melanosomes to keratinocytes, and inhibiting the release of melanin to keratinocytes. It also innovatively expands the pathway of decomposing melanin through melanocyte autophagy. Although the whitening effect can be enhanced through a variety of whitening targets, the way to improve skin color is also around the synthesis and metabolism of melanin, which is difficult to meet consumers' needs for improving skin color such as removing yellowness and uniform skin color. Summary of the invention
[0004] In order to solve the above problems, the present invention provides a skin color improving composition, a preparation method and an application thereof, which can improve skin color from multiple angles and has a significant whitening effect by optimizing the active ingredient combination of 3-o-ethyl ascorbic acid, carnosine, reed extract, licorice root extract, salvia miltiorrhiza root extract, angelica root extract, wolfberry root extract and cornus officinalis fruit extract.
[0005] On the one hand, the present invention provides a skin color improving composition, which comprises at least the following components by weight: 1-5 parts of 3-o-ethyl ascorbic acid, 0.01-1 parts of carnosine, 0.01-0.5 parts of reed extract, 0.01-0.5 parts of liquorice root extract, 0.001-0.1 parts of salvia miltiorrhiza root extract, 0.001-0.1 parts of angelica root extract, 0.001-0.1 parts of wolfberry root extract, and 0.001-0.1 parts of cornus officinalis fruit extract.
[0006] Preferably, the skin color improving composition comprises at least the following components, by weight: 0.5-2 parts of 3-o-ethyl ascorbic acid, 0.05-0.3 parts of carnosine, 0.01-0.16 parts of reed extract, 0.01-0.12 parts of licorice root extract, 0.005-0.1 parts of salvia miltiorrhiza root extract, 0.005-0.1 parts of angelica root extract, 0.005-0.1 parts of wolfberry root extract, and 0.005-0.1 parts of cornus officinalis fruit extract.
[0007] As a preferred technical solution, the skin color improving composition includes at least the following components by weight: 1-2 parts of 3-o-ethyl ascorbic acid, 0.05-0.15 parts of carnosine, 0.01-0.1 parts of reed extract, 0.01-0.1 parts of licorice root extract, 0.01-0.05 parts of salvia root extract, 0.01-0.05 parts of angelica root extract, 0.01-0.05 parts of wolfberry root extract, and 0.01-0.05 parts of Cornus officinalis fruit extract.
[0008] The composition provided by the present invention effectively inhibits the activity of tyrosinase through the combined action of 3-o-ethyl ascorbic acid, carnosine, reed extract, liquorice root extract, salvia miltiorrhiza root extract and angelica root extract, interferes with the biosynthesis of melanin in multiple ways from the source, and thus promotes skin whitening. The possible reason is that after the above active substances are combined, they can achieve obvious skin color improvement effects through different mechanisms. They can not only achieve the effect of whitening the skin by inhibiting melanocyte-stimulating hormone (α-MSH) in keratinocytes (HaCaT) and melanocytes (B16F10), increasing the autophagosomes that engulf melanosomes in B16F10 cells, and regulating the cAMP response element binding protein (CREB) / microphthalmia-associated transcription factor (MITF) / tyrosinase pathway in B16F10 cells, but also quench the reactive carbonyl substances against advanced glycation end products (AGE) / advanced fat oxidation end products (ALE) precursors, reduce the oxidation of sugars and lipids, and react with active substances in the body to prevent elastin and collagen from undergoing non-enzymatic glycosylation reactions to generate AGES or reacting with glycosylated protein products, thereby preventing further cross-linking of glycosylated proteins, thereby reducing the production of melanin and lipofuscin, preventing skin dullness, and maintaining skin elasticity. Additionally, it acts through direct antioxidant mechanisms and by chelating reactive carbonyl groups (RCS), a byproduct of lipid and glucose oxidation, thereby inhibiting the production of advanced glycation end products (AGE) and advanced lipoxidation end products (ALE).
[0009] Furthermore, the composition provided by the present invention can also improve the microcirculation of the skin, promote the removal of metabolic waste in the skin capillaries, provide sufficient nutrition for fibroblasts and collagen, improve the original dull complexion and pigmentation of the skin, and inhibit the production of pro-inflammatory cytokines, repair skin cell damage, and improve the skin barrier function. Specifically, on the one hand, by improving the blood microcirculation of the skin, promoting the exchange of substances in the capillaries, providing sufficient nutrition to fibroblasts and collagen and removing metabolic waste, it can inhibit the activity of tyrosinase and hinder the polymerization of 5,6-dihydroxyindole to inhibit the formation of melanin, while down-regulating the expression of MMP-1 and MMP-3, inflammatory cytokines (such as IL-6, TNF-α and IL-10) and up-regulating the activity of antioxidant enzymes (SOD, GSH-Px) to reduce the skin photoaging caused by ultraviolet rays, thereby achieving the effect of improving skin color; on the other hand, it can up-regulate the microcirculation factor (NO) and VEGF of human dermal microvascular endothelial cells (HDMEC), and collagen I and collagen I of human dermal fibroblasts (HDF). It can also inhibit the expression of matrix metalloproteinase-1 (MMP-1) in HDF to inhibit the degradation of collagen, improve the firmness and elasticity of the skin, improve the microcirculation of the skin, promote the repair of skin tissue, inhibit the activity of tyrosinase, limit the production rate of melanin, and achieve the effect of lightening spots; in addition, it can promote the synthesis of collagen and inhibit the degradation of collagen in human dermal fibroblasts, prevent or alleviate skin wrinkles and photoaging caused by ultraviolet rays, and can also prevent the expression of microphthalmia-associated transcription factor (MITF) by interfering with the extracellular signal-regulated kinase (ERK) / stress-activated kinase 1 (MSK1) / cAMP response element binding protein (CREB) axis to inhibit the production of melanin in B16F10 cells, thereby achieving a whitening effect.
[0010] The composition provided by the present invention is further combined with wolfberry root extract and cornelian fruit extract to inhibit collagenase and elastase activity, upregulate collagen expression, improve skin firmness and elasticity, and achieve the beneficial effects of improving skin color, skin firmness and elasticity from multiple angles. Specifically, on the one hand, by reducing the level of reactive oxygen species (ROS) and the expression of matrix metalloproteinases, enhancing the intrinsic antioxidant defense system, thereby increasing the collagen content in the skin, improving the skin erythema and wrinkles caused by ultraviolet rays, and increasing the expression of polyfilament protein, involucrin, loricrin and antioxidant proteins to improve the skin barrier function; on the other hand, inhibiting collagenase and elastase activity, slowing down the decline in skin elasticity, and inhibiting the production of proinflammatory cytokines IL-6, IL-8 and TNF-α to prevent skin cell damage caused by free radicals.
[0011] On the other hand, the present invention provides a method for preparing a skin color improving composition, wherein 3-o-ethyl ascorbic acid, carnosine, reed extract, licorice root extract, salvia miltiorrhiza root extract, angelica root extract, wolfberry root extract, and cornus officinalis fruit extract are mixed to obtain the skin color improving composition.
[0012] The skin color improving composition provided by the present invention has high application stability, has the characteristics of low-quantity and high-efficiency addition, effectively reduces the production cost of subsequent products, meets the use requirements for a longer period of time, and has high market promotion value.
[0013] Another third aspect of the present invention provides an application of a skin color improving composition, which is applied to the preparation of skin care products with skin color improving effects. The amount of the skin color improving composition added to the skin care products with skin barrier repair effects is 1-10wt%, preferably 3-6wt%.
[0014] As a preferred technical solution, the skin color improving composition is used for preparing a facial cream with skin color improving effect. Calculated by mass percentage, the raw materials for preparing the facial cream with skin color improving effect at least include: 1-10% soothing repair composition, 5-25% moisturizer, 0.1-1% thickener, 5-20% emollient, 1.5-12% emulsifier, 0.1-2% conditioner, 0.01-0.05% chelating agent, 0.1-1.5% antioxidant, 0.1-0.6% preservative, 0.01-0.05% fragrance, and deionized water to make up the balance.
[0015] Preferably, the moisturizer is selected from at least one of butylene glycol, 1,2-hexanediol, 1,2-pentanediol, glycerol, inositol, dipropylene glycol, and glycerol glucoside, preferably a combination of butylene glycol, 1,2-hexanediol, 1,2-pentanediol, glycerol, inositol, dipropylene glycol, and glycerol glucoside.
[0016] Preferably, the thickener is selected from at least one of acrylates, carbomers, and xanthan gum, preferably acrylates (esters) / C10-30 alkyl acrylate cross-linked polymer.
[0017] Preferably, the emollient is selected from at least one of soluble collagen cross-linked polymer, cetyl ethylhexanoate, white meadowfoam seed oil, polydimethylsiloxane, and phytosteryl oleate, and preferably is a combination of soluble collagen cross-linked polymer, cetyl ethylhexanoate, white meadowfoam seed oil, polydimethylsiloxane, and phytosteryl oleate.
[0018] Preferably, the emulsifier is selected from at least one of cetearyl alcohol, cetearyl olivate, sorbitan olivate, monoglyceride citrate, and polysorbate 40, preferably a combination of cetearyl alcohol, cetearyl olivate, sorbitan olivate, monoglyceride citrate, and polysorbate 40.
[0019] Preferably, the conditioning agent is selected from at least one of ceramide NP, fibronectin, ascorbyl palmitate, olive leaf extract, β-sitosterol, palmitoyl pentapeptide-4, acetyl tetrapeptide-5, and acetyl hexapeptide-8, and preferably a combination of ceramide NP, fibronectin, ascorbyl palmitate, olive leaf extract, β-sitosterol, palmitoyl pentapeptide-4, acetyl tetrapeptide-5, and acetyl hexapeptide-8.
[0020] Preferably, the preservative is selected from at least one of phenoxyethanol, p-hydroxyacetophenone and 1,2-hexanediol, preferably p-hydroxyacetophenone.
[0021] Preferably, the chelating agent is disodium ethylenediaminetetraacetate.
[0022] Preferably, the antioxidant is a combination of tocopherol (vitamin E) and sodium bisulfite.
[0023] Preferably, the raw materials for preparing the facial cream with skin color improving effect specifically include, by mass percentage: 1-2% 3-o-ethyl ascorbic acid, 1-2% yeast fermentation lysate filtrate, 0.5-1.5% chlorella fermentation product, 0.05-0.15% carnosine, 0.01-0.1% reed extract, 0.01-0.1% licorice root extract, 0.01-0.1% salvia root extract, 0.01-0.05% angelica root extract, 0.01-0.05% wolfberry root extract, 0.01-0.05% cornelian fruit extract, 0.01-0.05% galactosyl yeast fermentation product filtrate, 2-6% butylene glycol, 1,2-hexanediol Alcohol 0.1-1%, 1,2-pentanediol 0.1-1%, glycerin 2-6%, inositol 0.5-3%, dipropylene glycol 0.1-2%, glyceryl glucoside 0.1-1%, acrylates / C10-30 alkyl acrylate crosspolymer 0.1-1%, soluble collagen crosspolymer 0.01-0.3%, cetyl ethylhexanoate 2-5%, white meadowfoam seed oil 0.5-3%, polydimethylsiloxane 0.2-2%, phytosteryl oleate 0.1-1%, cetearyl alcohol 0.5-3%, cetearyl olive oil ester 0.3-2%, sorbitan olive oil ester 0.3-2%, monoglyceride citrate 0.5-3%, polysorbate-40 0.2-2%, ceramide NP 0.01-0.2%, fibronectin 0.00005-0.001%, ascorbyl palmitate 0.1-1%, olive leaf extract 0.01-0.1%, β-sitosterol 0.005-0.2%, palmitoyl pentapeptide-4 0.0001-0.002%, acetyl tetrapeptide-5 0.0001-0.002%, acetyl hexapeptide-8 0.0005-0.002%, disodium ethylenediaminetetraacetic acid 0.01-0.05%, tocopherol (vitamin E) 0.1-1%, sodium bisulfite 0.01-0.1%, p-hydroxyacetophenone 0.1-0.6%, lemon (CITRUS AURANTIFOLIA) oil 0.01-0.05%, and deionized water to make up the balance.
[0024] Preferably, the preparation method of the facial cream having skin color improving effect is:
[0025] (1) Pre-prepared liquid C: 1 / 10 weight of water, yeast fermentation lysate filtrate, Chlorella fermentation product, 1,2-hexanediol, 1,2-pentanediol, soluble collagen cross-linked polymer, galactosyl yeast fermentation product filtrate, 3-o-ethyl ascorbic acid, Phragmites communis extract, Glycyrrhiza uralensis root extract, Salvia miltiorrhiza root extract, Angelica polymorpha sinensis root extract, Lycium chinense root extract, Cornus officinalis fruit extract, dipropylene glycol, polysorbate-40, acetyl hexapeptide-8, acetyl tetrapeptide-5, palmitoyl pentapeptide-4, glyceryl glucoside, olive leaf extract, fibronectin, carnosine, and sodium bisulfite are stirred and dissolved uniformly for later use;
[0026] (2) Pre-made liquid A: Mix the remaining water, butylene glycol, glycerol, p-hydroxyacetophenone, inositol, acrylic acid (esters) / C10-30 alkyl acrylate cross-linked polymer, and disodium EDTA in sequence, heat to 80° C., stir until completely dissolved, and keep warm for later use;
[0027] (3) Pre-made liquid B: the raw materials caprylic / capric triglyceride, cetyl ethylhexanoate, cetearyl alcohol, sorbitan olivate, monoglyceride citrate, Limnanthes alba seed oil, polydimethylsiloxane, phytosteryl oleate, β-sitosterol, ascorbyl palmitate, tocopherol (vitamin E), and ceramide NP are mixed in sequence and heated to 80° C. and stirred until the mixture is uniformly mixed, and the mixture is kept warm for later use;
[0028] (4) Transfer preformed liquid A into the emulsification pot and stir, then transfer preformed liquid B into the emulsification pot, stir and homogenize, and cool to 40°C after emulsification.
[0029] (5) Transfer the pre-prepared liquid C and lemon oil into an emulsifying pot and stir evenly.
[0030] The present invention optimizes the raw material formulation and introduces the composition into the facial cream system to prepare a facial cream with high stability, excellent repairing, soothing, moisturizing, skin nourishing and skin firmness improvement effects, and the product is highly safe and can meet the usage needs of different groups of people.
[0031] Beneficial Effects
[0032] 1. The present invention provides a skin color improving composition, a preparation method and an application thereof. By optimizing the active ingredient combination to form a composition of 3-o-ethyl ascorbic acid, carnosine, reed extract, licorice root extract, salvia miltiorrhiza root extract, angelica root extract, wolfberry root extract and cornus officinalis fruit extract, the skin color can be improved from multiple angles, and the whitening effect is remarkable.
[0033] 2. The composition provided by the present invention effectively inhibits the activity of tyrosinase through the combined action of 3-o-ethyl ascorbic acid, carnosine, reed extract, licorice root extract, salvia miltiorrhiza root extract, and angelica root extract, thereby interfering with the biosynthesis of melanin in multiple ways from the source and promoting skin whitening.
[0034] 3. The composition provided by the present invention can also improve the microcirculation of the skin, promote the removal of metabolic waste in the skin capillaries, provide sufficient nutrition for fibroblasts and collagen, improve the original dull complexion and pigmentation of the skin, inhibit the production of pro-inflammatory cytokines, repair skin cell damage, and improve the skin barrier function.
[0035] 4. The composition provided by the present invention is further combined with wolfberry root extract and cornus officinalis fruit extract to inhibit the activity of collagenase and elastase, upregulate the expression of collagen, improve the firmness and elasticity of the skin, and achieve the beneficial effect of improving skin color, skin firmness and elasticity from multiple angles.
[0036] 5. The skin color improving composition provided by the present invention has high application stability, low-volume and high-efficiency addition characteristics, effectively reduces the production cost of subsequent products, meets the requirements of long-term use, and has high market promotion value.
[0037] 6. The present invention optimizes the raw material formulation and introduces the composition into the facial cream system to prepare a facial cream with high stability, excellent repairing, soothing, moisturizing, skin nourishing and skin firmness improvement effects, and the product is highly safe and can meet the needs of different groups of people. BRIEF DESCRIPTION OF THE DRAWINGS
[0038] Figure 1 This is a graph showing the moisture content of the skin stratum corneum at different test time points in the repairing and soothing efficacy test of the facial cream product in Example 1.
[0039] Figure 2 This is a graph showing the changes in epidermal water loss at different test time points in the repairing and soothing efficacy test of the facial cream product in Example 1.
[0040] Figure 3 This is the OCR analysis diagram of mitochondria in the test results of the water-based cosmetics in regulating cellular energy metabolism in Example 2. DETAILED DESCRIPTION
[0041] Example 1
[0042] Example 1 of the present invention provides a facial cream with skin color improving effect. The formula is shown in Table 1 by mass percentage.
[0043] Table 1
[0044]
[0045]
[0046]
[0047] The preparation method of the facial cream with skin color improving effect is:
[0048] Preformed liquid C: stir and dissolve 1 / 10 weight of water, 5, 6, 7, 8, 9, 11, 13, 19, 20, 21, 22, 23, 24, 28, 29, 30, 31, 32, 33, 36, 39, 40, 41 in Table 1 in sequence, and set aside; Preformed liquid A: mix the remaining water, 2, 4, 10, 14, 18, 43 in Table 1 in sequence, heat to 80°C, stir until completely dissolved, and keep warm for later use;
[0049] Preformed liquid B: Mix raw materials 3, 12, 15, 17, 25, 26, 27, 34, 35, 37, 38, and 42 in Table 1 in sequence, heat to 80°C, stir until mixed evenly, and keep warm for later use;
[0050] Transfer preformed liquid A into the emulsification pot and stir, then transfer preformed liquid B into the emulsification pot, stir and homogenize, and cool to 40°C after emulsification.
[0051] Transfer prefabricated liquid C and raw material No. 44 into the emulsifying pot and stir evenly.
[0052] Example 2
[0053] Example 2 of the present invention provides an aqueous cosmetic having the function of regulating cellular energy metabolism. The formula is shown in Table 2 in terms of mass percentage.
[0054] Table 2
[0055]
[0056]
[0057] The preparation method of the aqueous cosmetic having the function of regulating cell energy metabolism is as follows:
[0058] Add ingredients 1-10 in Table 5 into a stirring pot and stir to dissolve evenly.
[0059] Performance Testing
[0060] 1. Stability test: The facial cream provided in Example 1 was subjected to a stability test. The test results are shown in Table 1 below. The results show that the facial cream prepared by adding the composition has excellent physical and chemical stability.
[0061] Table 1
[0062]
[0063]
[0064] 2. Safety test: A human patch test was conducted on the cream product provided in Example 1, with a total of 30 healthy volunteers, including 10 males and 30 females; the youngest age was 20 years old, the oldest age was 40 years old; the average age was 23.28±3.72 years old. Both men and women were accepted. A standard patch tester (Beijing Yida) was used, and a closed patch test method was used. About 0.020-0.025g of the test substance was placed in the patch tester, and a medical tape was applied to the back of the subject. The test substance was removed after 24 hours, and the skin reaction was observed at 0.5, 24, and 48 hours after the patch was removed. The results were recorded according to the skin reaction grading standard in the "Technical Specifications for Safety of Cosmetics" (2015 edition). The skin adverse reaction grading standard is shown in Table 3, and the results are shown in Table 4.
[0065]
[0066] Table 4
[0067] Rating Example 1 0.5(h) 0 24(h) 0 48(h) 0
[0068] As shown in Table 4, the facial cream product provided in Example 1 did not show a positive reaction in 30 people in the human skin closed patch test. According to the provisions of the "Technical Specifications for Safety of Cosmetics" (2015 edition), the test substance did not cause adverse skin reactions in this batch of subjects. It can be seen that the facial cream product provided in Example 1 of the present invention can achieve a good safety effect.
[0069] 3. Repair and soothing effect test.
[0070] 3.1 Sample information
[0071] Sample Chinese name: Example 1 Face Cream
[0072] 3.2 Test Instruments
[0073] Capacitive moisture tester Corneometer CM825, transepidermal water loss tester Tewameter TM300, VISIA camera + IPP software analysis
[0074] 3.3 Test Principle
[0075] 3.3.1 Capacitive Water Loss Tester CorneometerCM Test Principle: The capacitance method is used to determine the moisture content of the stratum corneum of human skin. It is based on the significant difference in the dielectric constants of water and other substances. According to the different moisture content of the stratum corneum of the skin, the measured capacitance value of the skin is different, and its parameters can represent the moisture content of the skin. 3.3.2 Transepidermal Water Loss Tester Tewameter TM300: The Tewameter probe has a sensor inside to test relative humidity and temperature. The transepidermal water loss TEWL value (Transepidermal Water Loss) is expressed in g / h / m 2 It is described in grams per square meter per hour. As long as the skin barrier layer is slightly damaged, even if it is very small and cannot be seen by the human eye, the TEWL value will increase.
[0076] 3.4 Experimental conditions and volunteer requirements
[0077] 3.4.1 Test environment conditions
[0078] Test environment temperature: 20℃-22℃, humidity: 40%-60%, and real-time dynamic monitoring.
[0079] 3.4.2 Number of volunteers: 10 effective volunteers
[0080] 3.4.3 Volunteer Requirements
[0081] (1) Aged between 18 and 65 (excluding pregnant or breastfeeding women).
[0082] (2) Patients who have no serious systemic diseases, immunodeficiency or autoimmune diseases, and the tested area has not received any skin treatment, cosmetic treatment or other tests that may affect the results.
[0083] (3) Those without active allergic diseases.
[0084] (4) Those who are not highly sensitive.
[0085] (5) Those who have not used hormone drugs or immunosuppressants in the past month.
[0086] (6) The subject has not participated in other clinical trials currently or in the past three months.
[0087] 3.5 Test Method
[0088] 3.5.1 Preparation before testing
[0089] Do not use any products (cosmetics or topical drugs) 2-3 days before the test. Before the test, the subjects need to clean their faces with clean water. Before the formal test, sit quietly in a room that meets the test conditions for at least 20 minutes without drinking water or beverages. Keep your face exposed and relaxed.
[0090] 3.5.2 Determination
[0091] The initial value of the test product application area (before the sample is used) is measured in parallel for at least 3 times in each area. The test sample is applied once at a dosage of (2.0±0.1) mg / cm2, and then measured again at specified time points such as 14d and 28d.
[0092] 3.6 Data Analysis
[0093] 3.6.1 The measured value of the test area is recorded as the average of three measurements, and descriptive statistics are performed on the above average, including quantity, mean, standard deviation, minimum value, median value and maximum value.
[0094] 3.6.2 Normal distribution test
[0095] The test data at different time points in each region were tested for normal distribution. If the asymptotic significance (two-sided) value of the normality test was > 0.050, the data series followed a normal distribution.
[0096] 3.6.3 Difference Analysis
[0097] The data at different time points were analyzed for differences. When the two groups of data were normally distributed at the same time, the paired T test was used to analyze the differences between the two groups of data; when the two groups of data were not normally distributed at the same time, the rank sum test was used to analyze the differences between the two groups of data.
[0098] 3.6.4 Evaluation criteria
[0099] If the significance level of the statistical method is p<0.050, it means that there is a statistically significant difference between the subjects before and after using the samples; if the significance level of the statistical method is p≥0.050, it means that there is no statistically significant difference between the subjects before and after using the samples.
[0100] 3.7 Experimental results see Figure 1-2
[0101] 3.8 Conclusion
[0102] The facial cream provided in Example 1 significantly increases the skin water content after 14 days of use and stably increases within 28 days; the transepidermal water loss TEWL value significantly decreases after 14 days, and this facial cream for staying up late has a repairing effect.
[0103] 4. Repair, moisturizing, nourishing and firming efficacy test:
[0104] 4.1 Test Purpose
[0105] The test sample (Example 1 cream) was used by Asian adult female subjects for 28 consecutive days under normal conditions. The moisture content of the skin stratum corneum, transepidermal water loss, skin oil content, skin elasticity R2 value, and skin firmness F4 value were measured using an instrument probe to evaluate the efficacy of the test sample in repairing, moisturizing, nourishing, and firming.
[0106] 4.2 Instrument test results
[0107] (1) Water content of the stratum corneum of the skin: After using the sample for 28 days, the change rate was 43.30%, which was significantly different from before use. The increase in the measured value indicated that the water content of the stratum corneum of the skin increased.
[0108] (2) Transepidermal water loss: After using the sample for 28 days, the change rate was -8.63%, which was significantly different from before use. The measured value decreased, indicating that the skin barrier function was improved.
[0109] (3) Skin oil content: After using the sample for 28 days, the change rate was 71.43%, which was significantly different from before use. The increase in the measured value indicated that the skin oil content increased.
[0110] (4) Skin elasticity R2 value: After using the sample for 28 days, the change rate was 8.88%, which was significantly different from before use. The increase in the measured value indicated that the skin elasticity was improved.
[0111] (5) Skin firmness F4 value: After using the sample for 28 days, the change rate was -32.19%, which was significantly different from before use. The measured value decreased, indicating that the skin firmness was improved.
[0112] 4.3 Subject Self-Assessment
[0113] After using the test sample for 28 days, the overall satisfaction of the 32 subjects with the test sample (Example 1 cream) was 90.6%.
[0114] 4.4 Test Conclusion
[0115] 32 Asian adult female subjects aged 23-40 years old used the test sample (Example 1 cream) for 28 consecutive days under normal conditions. The moisture content of the skin stratum corneum, the transepidermal water loss, the skin oil content, the skin elasticity R2 value, and the skin firmness F4 value were measured by instrument probes. The results showed that the test sample (Example 1 cream) had the effects of repairing, moisturizing, nourishing, and firming after 28 days of use.
[0116] 5. Skin color improvement efficacy test:
[0117] 5.1 Test method: 100 subjects, aged 18-28 years old, 89 females, 11 males, people who have the habit of staying up late. Skin type distribution: dry skin (8 people), mixed dry skin (11 people), mixed oily skin (24 people), oily skin (57 people); the test skin area is the whole face; the test sample is the cream in Example 1 of the cosmetics. The specific method is as follows: twice a day, 2-3 pumps each time, evenly apply to the facial skin; use for 7 consecutive days; observe the facial skin condition and fill in the feedback questionnaire at the agreed time;
[0118] 5.2 Evaluation method: Users’ experience and preferences were collected through online questionnaires and one-on-one interviews. The results are shown in Table 5.
[0119] Table 5
[0120] Efficacy evaluation dimensions Day 1 Day 3 Day 7 Feel your skin tone become more even 27.70% 51.20% 61.20% Feel the anti-yellowing effect 42.20% 67.10% 82.10%
[0121] It can be seen that with the use of the cream of Cosmetic Example 1, the skin color of the subjects is significantly improved, which is reflected in the improvement of skin color uniformity and the improvement of dark yellow skin color. As the use time increases, the proportion of subjects who feel the above effects also shows a significant growth trend. After testing, the cream of Cosmetic Example 1 has a significant effect of improving skin color, and as the use time increases, the proportion of subjects who feel the effect of improving skin color also shows a significant growth trend.
[0122] 6. Test the efficacy of regulating cell energy metabolism.
[0123] 6.1 Experimental Principle
[0124] OCR (Oxygen Consumption Rate) refers to the rate at which cells consume oxygen. Energy metabolism analyzers are used to measure cellular energy metabolism, and processes such as mitochondrial function of cells are evaluated by measuring the oxygen consumption rate (OCR) of cells. The measurement principle of OCR is as follows: the energy metabolism analyzer determines OCR by measuring the changes in dissolved oxygen content in the culture medium surrounding the cells. During the measurement process, cells are placed in specific oxygen-consuming reagents, such as thiazole compounds, which interact with the mitochondrial respiratory chain in the cells, resulting in changes in the oxygen consumption rate. The energy metabolism analyzer calculates the OCR of the cells by measuring the changes in oxygen-consuming reagents and dissolved oxygen content in the culture medium surrounding the cells.
[0125] 6.2 Experimental basis
[0126] This test refers to the "Seahorse Energy Metabolism Analyzer: Oxygen Consumption Rate (OCR) Test". According to the judgment criteria based on the laboratory method "Seahorse Energy Metabolism Analyzer: Oxygen Consumption Rate (OCR) Test", the mitochondrial function of the cells was evaluated by measuring the oxygen consumption rate (OCR) of the cells by comparing with the negative control.
[0127] 6.3 Test materials
[0128] 6.3.1 Main reagents are shown in Table 6. The test sample is the aqueous cosmetic provided in Example 2.
[0129] Table 6
[0130]
[0131] 6.3.2 Instruments and equipment See Table 7
[0132] Table 7
[0133]
[0134] 6.4 Test steps
[0135] 6.4.1 Inoculation of cells: Take 100 μL of 105 / mL single cell suspension of each group and incubate at 37°C, then add 150 mL of culture medium, divide into groups according to the requirements, and then test on the machine;
[0136] 6.4.2 Test medium change: remove 175 μL of growth medium, use 600 μL of special test medium, wash twice, and finally add 525 μL. Observe the continuity of cells in each well under a microscope, and place the cell plate in a non-CO2 incubator for 1 hour;
[0137] 6.4.3 Add 75 μL of drugs to the four drug addition slots in each well according to the experimental design, and add oligomycin, FCCP, and antimycin A in sequence.
[0138] 6.4.4 Editing instrument methods and calibrating calibration plates;
[0139] 6.4.5 Replace the calibration plate with the cell plate and run.
[0140] 6.4.6 Result determination: The oxygen consumption of the experimental group was significantly higher than that of the control group (statistically significant, P<0.05).
[0141] 6.5 Test results
[0142] See also Figure 3, Sample A in the analysis graph refers to the test sample XT-ReVigor MIX A. The * mark in the above figure indicates the difference, and the equivalent T test: if p < 0.05, it indicates that there is a significant difference between the data and it is statistically significant; if p > 0.05, it indicates that there is no significant difference between the data.
[0143] OCR result analysis:
[0144] (1) Under the three analytical conditions of basal respiration, ATP production (ATP-linked respiration), and maximum respiration, there was no significant difference in the indicators of Control+A compared with the Control group, indicating that sample A had no significant effect on the aerobic respiration of cell mitochondria;
[0145] (2) Compared with the Control group, the basal oxygen consumption (Basal Respiration), ATP synthesis oxygen consumption (ATP production, ATP-linked respiration), maximum oxygen consumption (Maximal Respiration) and spare respiratory capacity of the UV group were significantly reduced under the four analytical conditions, indicating that UV has a significant inhibitory effect on the aerobic respiration function of mitochondria.
[0146] (3) Compared with Control+A, the basal oxygen consumption (Basal Respiration), ATP synthesis oxygen consumption (ATP production, ATP-linked respiration), maximum oxygen consumption (Maximal Respiration) and spare respiratory capacity of the UV+A group were significantly reduced under the four analytical conditions, indicating that UV has a significant inhibitory effect on the aerobic respiration function of mitochondria.
[0147] (4) Compared with the UV group, the basal oxygen consumption (Basal Respiration), ATP production (ATP-linked respiration), maximum oxygen consumption (Maximal Respiration) and spare respiratory capacity of the UV+A group were significantly increased under the four analytical conditions, indicating that sample A has a potential role in restoring the functional damage of mitochondrial aerobic respiration caused by UV.
[0148] (5) Compared with the Control group, the proton leak oxygen consumption (Proton Leak) in the UV group was reduced, which can improve the mitochondrial coupling efficiency to a certain extent and regulate the ability of ATP synthase to produce ATP.
[0149] (6) There was no significant difference in non-mitochondrial oxygen consumption among the groups, indicating that the changes in oxygen consumption in the experiment were mainly caused by the mitochondrial pathway, eliminating the error caused by changes in oxygen consumption in the non-mitochondrial pathway.
[0150] 6.6 Test Conclusion
[0151] This test was conducted with reference to the Seahorse Energy Metabolism Analyzer: Oxygen Consumption Rate (OCR) Test. According to the criteria of the laboratory method Seahorse Energy Metabolism Analyzer: Oxygen Consumption Rate (OCR) Test, by comparing the test groups, under normal cell conditions, the aqueous cosmetic provided in Example 2 had no effect on the function of mitochondria; under UV damage model conditions, the aqueous cosmetic provided in Example 2 had a positive effect on mitochondria, which was reflected in the significant increase in ATP production.
Claims
1. A skin color improving composition, It is characterized in that By weight, it includes at least the following components: 1-5 parts of 3-o-ethyl ascorbic acid, 0.01-1 parts of carnosine, 0.01-0.5 parts of reed extract, 0.01-0.5 parts of licorice root extract, 0.001-0.1 parts of salvia miltiorrhiza root extract, 0.001-0.1 parts of angelica root extract, 0.001-0.1 parts of wolfberry root extract, and 0.001-0.1 parts of cornus officinalis fruit extract.
2. The skin color improving composition according to claim 1, It is characterized in that The skin color improving composition comprises at least the following components by weight: 0.5-2 parts of 3-o-ethyl ascorbic acid, 0.05-0.3 parts of carnosine, 0.01-0.16 parts of reed extract, 0.01-0.12 parts of licorice root extract, 0.005-0.1 parts of salvia miltiorrhiza root extract, 0.005-0.1 parts of angelica root extract, 0.005-0.1 parts of wolfberry root extract, and 0.005-0.1 parts of cornus officinalis fruit extract.
3. A method for preparing the skin color improving composition according to claim 1 or 2, It is characterized in that The skin color improving composition is obtained by mixing 3-o-ethyl ascorbic acid, carnosine, reed extract, liquorice root extract, salvia root extract, angelica root extract, wolfberry root extract and cornus fruit extract.
4. Use of the skin color improving composition according to claim 1 or 2, It is characterized in that The invention is applied to the preparation of skin care products with skin color improving effect, wherein the amount of the skin color improving composition added to the skin care products with skin barrier repairing effect is 1-10wt%.
5. Use of the skin color improving composition according to claim 4, It is characterized in that The skin color improving composition is used for preparing a facial cream with skin color improving effect. The raw materials for preparing the facial cream with skin color improving effect include at least, by mass percentage: 1-10% of a soothing repairing composition, 5-25% of a moisturizer, 0.1-1% of a thickener, 5-20% of an emollient, 1.5-12% of an emulsifier, 0.1-2% of a conditioner, 0.01-0.05% of a chelating agent, 0.1-1.5% of an antioxidant, 0.1-0.6% of a preservative, 0.01-0.05% of a fragrance, and the balance is made up of deionized water.
6. Use of the skin color improving composition according to claim 5, It is characterized in that The moisturizing agent is selected from at least one of butylene glycol, 1,2-hexanediol, 1,2-pentanediol, glycerol, inositol, dipropylene glycol, and glycerol glucoside.
7. Use of the skin color improving composition according to claim 5, It is characterized in that The emollient is selected from at least one of soluble collagen cross-linked polymer, cetyl ethylhexanoate, meadowfoam seed oil, polydimethylsiloxane, and phytosteryl oleate.
8. Use of the skin color improving composition according to claim 5, It is characterized in that The emulsifier is selected from at least one of cetearyl alcohol, cetearyl olivate, sorbitan olivate, monoglyceride citrate, and polysorbate-40.
9. Use of the skin color improving composition according to claim 5, It is characterized in that The conditioning agent is selected from at least one of ceramide NP, fibronectin, ascorbyl palmitate, olive leaf extract, β-sitosterol, palmitoyl pentapeptide-4, acetyl tetrapeptide-5, and acetyl hexapeptide-8.
10. Use of the skin color improving composition according to claim 5, It is characterized in that The thickener is selected from at least one of acrylates, carbomers and xanthan gum.
Citation Information
Cited By
Evaluation mechanism and test method for efficacy of whitening raw material
CN115267160A
